Cargando…

P111 Forced oscillation techniques – is it useful for the monitoring of adult patients with cystic fibrosis in the era of CFTR modulators

Detalles Bibliográficos
Autores principales:	Markelić, I., Batarilo Hađar, M., Štajduhar, A., Bambir, I., Tješić-Drinković, D., Odobašić Palković, T., Lalić, I., Vukić Dugac, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. Published by Elsevier B.V. 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250902/ http://dx.doi.org/10.1016/S1569-1993(23)00486-1

Ejemplares similares

P077 Vaccination of patients with cystic fibrosis during the COVID-19 pandemic in Croatia
por: Markelić, I., et al.
Publicado: (2022)

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia
por: Bambir, I., et al.
Publicado: (2022)

P091 Regularity of check-ups at the cystic fibrosis centre in the time of COVID-19 pandemic
por: Todorić, I., et al.
Publicado: (2021)

P221 Quality of life in adult and children with cystic fibrosis during the COVID-19 pandemic in Croatia
por: Odobasic Palkovic, T., et al.
Publicado: (2021)

68 Respiratory viral detection in children with cystic fibrosis (CF)
por: Tješić-Drinković, I., et al.
Publicado: (2015)

Cystic fibrosis presentation in del. F508 and p. Tyr109Glyfs compound heterozygote CFTR state: a case report
por: Turkalj, Mirjana, et al.
Publicado: (2019)

Lung Abscess: An Early Complication of Lung Transplantation in a Patient with Cystic Fibrosis
por: Markelić, I., et al.
Publicado: (2017)

ACUTE RESPIRATORY DISTRESS SYNDROME IN A FOUR-YEAR-OLD BOY WITH DIABETIC KETOACIDOSIS – CASE REPORT
por: Pavić, Ivan, et al.
Publicado: (2018)

Influence of disease severity, smoking status and therapy regimes on leukocyte subsets and their ratios in stable chronic obstructive pulmonary disease
por: Hlapčić, Iva, et al.
Publicado: (2020)

Pseudoaneurysm as an Etiological Cause of Hemoptysis in Extensive Tuberculosis
por: Mikanovic´, Martina, et al.
Publicado: (2023)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)

Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease
por: Markelić, Ivona, et al.
Publicado: (2022)

The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review
por: McKay, Isabelle R., et al.
Publicado: (2022)

The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?
por: Esposito, Renata, et al.
Publicado: (2023)

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators
por: Ribeiro, Carla M. P., et al.
Publicado: (2023)

Nintedanib treatment for bleomycin-induced lung injury - First report
por: Rnjak, Dina, et al.
Publicado: (2023)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

CFTR modulator therapies – Effect on life expectancy in people with cystic fibrosis
por: Balfour-Lynn, I.M., et al.
Publicado: (2022)

ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies
por: Mall, Marcus A.
Publicado: (2020)

Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)

Forced oscillations and respiratory system modeling in adults with cystic fibrosis
por: Lima, Adma N, et al.
Publicado: (2015)

Analysis of CFTR Mutation Spectrum in Ethnic Russian Cystic Fibrosis Patients
por: Petrova, Nika V., et al.
Publicado: (2020)

188: Cystic fibrosis kidney stone disease in the era of CFTR modulator use and the COVID-19 pandemic
por: Romano, S., et al.
Publicado: (2021)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2017)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
por: Moliteo, Evelina, et al.
Publicado: (2022)

CFTR modulators: transformative therapies for cystic fibrosis
por: Dwight, Mary, et al.
Publicado: (2021)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

The gut-lung axis in the CFTR modulator era
por: Lussac-Sorton, Florian, et al.
Publicado: (2023)

Relating the Disease Mutation Spectrum to the Evolution of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
por: Rishishwar, Lavanya, et al.
Publicado: (2012)

Fixing cystic fibrosis by correcting CFTR domain assembly
por: Okiyoneda, Tsukasa, et al.
Publicado: (2012)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Lived experiences of individuals with cystic fibrosis on CFTR-modulators
por: Page, Annelise, et al.
Publicado: (2022)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Nutritional impact of CFTR modulators in children with cystic fibrosis
por: Gaschignard, Margaux, et al.
Publicado: (2023)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
por: Dobi, Dorina, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
por: Marčetić, Dejan, et al.
Publicado: (2021)

National Guidelines for the Performance of the Sweat Test in Diagnosis of Cystic Fibrosis on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine and the Cystic Fibrosis Centre - Paediatrics and adults, University Hospital Centre Zagreb
por: Leniček Krleža, Jasna, et al.
Publicado: (2022)

Airway Inflammation and Host Responses in the Era of CFTR Modulators
por: Keown, Karen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d0gjur4hjncmhkoia7tknnch0b